Lactic acid bacteria (Lactobacillus) and Bifidobacteria are considered to be benign microorganisms that are not associated with pathogenicity. In addition, the Lab4 bacteria have been rigorously tested to show both their passage through the GI tract and colonisation of the gut.
Prior to selection, the bacteria in the Lab4 consortia were subjected to a rigorous two-phase testing process to enable the most appropriate strains to be selected.
This two-stage process included preliminary and secondary screening for strain suitability, durability, ‘competitivity’, antimicrobial properties, antibiotic susceptibilities and growth and storage capabilities.
But the ‘acid’ test is the efficacy of a particular probiotic in practice – does it stand up to its in-vitro characteristics in vivo?
The Lab4 consortia is supported by data showing benefits and symptom reduction in all of the following conditions:
(hover over image to see reference)